Effects of traditional Chinese medicines on serum lipid profiles and homocysteine in the ovariectomized rats

American Journal of Chinese Medicine

Volumn 32, Issue 4, 2004, Pages 541-550

  Lee, Su Chen ^a   Chang, Shun Jen ^a   Tsai, Li Yu ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

17 Estradiol; Chia wei hsiao yao san; Homocysteine; Kuei lu erh hsien chiao; Lipid profiles; Ovariectomized

Indexed keywords

ANGELICA ROOT; ATRACTYLODIS EXTRACT; BUPLEURUM ROOT; CERVI EXTRACT; CHIA WEI HSIAO YAO SAN; CHINESE DRUG; ESTRADIOL; ESTROGEN; GARDENIA EXTRACT; GINGER EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOELEN EXTRACT; HOMOCYSTEINE; KUEI LU ERH HSIEN CHIAO; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYCIUM EXTRACT; MENTHA EXTRACT; PAEONIA RADIX; PAEONIA SUFFRUTICOSA EXTRACT; PEPPERMINT OIL; PLANT EXTRACT; TESTUDINIS EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANGELICA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; ATRACTYLODIS; BUPLEURUM; CERVI; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; GARDENIA; GINGER; GINSENG; GLYCYRRHIZA; HOELEN; HYPERHOMOCYSTEINEMIA; LIPID BLOOD LEVEL; LYCIUM; MEDICINAL PLANT; MENTHA; NONHUMAN; OVARIECTOMY; PAEONIA; PAEONIA SUFFRUTICOSA; RAT; STATISTICAL SIGNIFICANCE; TESTUDINIS; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DRUGS, CHINESE HERBAL; ESTROGENS; FEMALE; HOMOCYSTEINE; KIDNEY FUNCTION TESTS; LIPIDS; LIVER FUNCTION TESTS; MEDICINE, CHINESE TRADITIONAL; MODELS, ANIMAL; OVARIECTOMY; RATS; RATS, LONG-EVANS; TRIGLYCERIDES;

EID: 4644330587     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X04002181     Document Type: Article

References (31)

1. Albright, F., P.H. Smith and A.M. Richardson. Postmenopausal osteoporosis: its clinical features. J. Am. Med. Assoc. 116: 2465-2474, 1941.
2. Barrett-Connor, E., R. Young, M. Notelovitz, J. Sullivan, B. Wiita, H.M. Yang and J. Nolan. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. J. Reprod. Med. 44: 1012-1020, 1999.
3. Barrett-Connor, E. and T.L. Bush. Estrogen and coronary heart disease in women. JAMA 265: 1861-1867, 1991.
4. Brown, M.S. and J.L. Goldstein. The estradiol stimulated lipoprotein receptor of rat liver. J. Biol. Chem. 254: 10454-10471, 1980.
5. Campos, H., P.W.F. Wilson, D. Jimenez, J.R. McNamara, J. Ordovas and E.J. Schaefer. Differences in apolipoproteins and low-density lipoprotein subfractions in postmenopausal women on and off estrogen therapy: results from the Framingham Offspring study. Metabolism 39: 1033-1038, 1990.
6. Christodoulakos, G., C. Panoulis, D. Rizos, T. Moustakarias, I. Panocas and G. Creatsas. Homocysteine and folate levels in postmenopausal women. Maturitas 39: 161-167, 2001.
7. Colvin, P.L., B.J. Auerbach, L.D. Case, W.R. Hazzard and D. Applebaum-Bowden. A dose-response relationship between sex steroid hormone induced changes in hepatic triglyceride lipase and high-density lipoprotein cholesterol in postmenopausal women. Metabolism 40: 1052-1056, 1991.
8. D'Angelo, A. and J. Sehlub. Homocysteine and thrombotic disease. Blood 90(1): 1-11, 1997.
9. Ferreri, L.F. and H.K. Natio. Simulation of hepatic cholesterol 7α-hydroxylase activity by administration of an estrogen (17β-estradiol-3-benzoate) to female rats. Steroids 29: 229, 1977.
10. Ferreri, L.F. and H.K. Natio. Effect of estrogens on rat serum cholesterol concentration: consideration of dose, type of estrogen, and treatment duration. Endocrinology 102: 1621-1627, 1978.
11. Fewster, M.E., R.E. Pirrie and D.A. Turner. Effect of estradiol benzoate on lipid metabolism in the rat. Endocrinology 80: 263-266, 1967.
12. Frolik, C.A., H.U. Bryant, E.C. Black, D.E. Magge and S. Chandrasekhar. Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCL, tamoxifen, estrogen and alendronate. Bone 18: 621-627, 1996.
13. Giri, S., P.D. Thompson, P. Taxel, J.H. Contois, J. Otvos, R. Allen, G. Ens, A.H.B. Wu and D.D. Waters. Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men. Atherosclerosis 137: 359-366, 1998.
14. Glueck, C.J., P. Shaw, J.E. Lang, T. Tracy, L. Sieve-Smith and Y. Wang. Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am. J. Cardiol. 75: 132-136, 1995.
15. Gökmen, O. and E.E.G.. Yapar. Hormone replacement therapy and lipid-lipoprotein concentrations. Eur. J. Obstet. Gynecol. Reprod. Biol. 85: 31-41, 1999.
16. Handdock, B.L., H.P. Marshak, J.J. Mason and G. Blix. The effect of hormone replacement therapy and exercise on cardiovascular disease risk factors in postmenopausal women. [Review]. Sports Med. 29: 39-49, 2000.
17. Henderson B.E., R.K. Ross and M.C. Pike. Hormonal chemoprevention of cancer in women. Science 259: 633-638, 1993.
18. Kalu, D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15: 175-192, 1991.
19. Liu, S.L. Treatment of metrorrhagia and metrostaxis at puberty in 103 cases with Kuei-lu-erh-hsien-chiao. Shaanxi Chin. Med. 6: 247, 1998.
20. Ma, P.T., T. Yamamoto, J.T. Goldstein and M.S. Brown. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 1-alpha ethinyl estradiol. Proc. Natl. Acad. Sci. USA 83: 792-796, 1986.
21. Madsen, J.S., S.R. Kristensen, N.A. Klitgaard, E.M. Bladbjerg, B. Abrahamsen, L. Stilgern and J. Jespersen. Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study. Am. J. Obstet. Gynecol. 187: 33-39, 2002.
22. Norman, R.J., I.H. Flight and M.C. Rees. Oestrogen and progestogen hormone replacement therapy for perimenopausal and postmenopausal women: weight and body fat distribution. Cochrane Database Syst. Rev. [computer file] (2): CD 001018, 2000.
23. Ozkan, Y., E. Ozkan and B. Simsek. Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int. J. Cardiol. 82: 269-277, 2002.
24. Pao, K.Y. and H. Chang. Treatment of menopausal syndrome with Chia-wei-hsiao-yao-san. Chin. Herbal Treat. 6: 40, 1998.
25. Rosenberg, L., C.H. Hennekens, B. Rosner, C. Belanger, K.J. Rothman and F.E. Speizer. Early menopause and the risk of myocardial infarction. Am. J. Obstet. Gynecol. 139: 47-51, 1981.
26. Stamler, J., D. Wentworth and J.D. Neaton. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the multiple risk factor intervention trial. JAMA 256: 2823-2828, 1986.
27. Stampfer, M.J., G.A. Colditz, W.C. Willett, J.E. Manson, B. Rosner, F.E. Speizer and C.H. Hennekens. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the nurses' health study. N. Engl. J. Med. 325: 756-762, 1991.
28. Wakatsuki, A. and Y. Sagara. Lipoprotein metabolism in postmenopausal and oophorectomized women. Obstet. Gynecol. 85: 523-538, 1995.
29. Wang, T.F. Treatment of menstrual pain in 25 cases with Kuei-lu-erh-hsien-chiao. Chin. Agric. Med. 11: 698-699, 1994.
30. Waynforth, H.B. and P.A. Flecknell. Experimental and Surgical Technique in the Rat, 2nd ed. Academic Press, 1992, pp. 276-278.
31. Windler, E.E., P.T. Kovanen, Y.S. Chao, M.S. Brown, R.J. Havel and J.L. Goldstein. The estradio-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apolipoproteins B and E. J. Biol. Chem. 255: 10464-10471, 1980.